Luminex provides clinical trial update on ARIES HSV 1&2 Assay

Luminex Corporation (NASDAQ: LMNX) today announced that testing at the clinical trial sites for the ARIES® HSV 1&2 Assay is now complete. The next steps, including site to site reproducibility testing, followed by data analysis and assembly of the data package for submission to the FDA, are now underway. In addition, the company has commenced clinical and analytical studies to evaluate the ARIES Clostridium difficile (C. difficile) Assay.

"We are very pleased with the progress we are making on the ARIES launch schedule. The system has met all of our expectations during the clinical trials phase for the initial launch assay, allowing us to rapidly complete the testing at the trial sites for the HSV 1&2 Assay," said Homi Shamir, President and CEO of Luminex. "The start of clinical trials for the ARIES C. difficile Assay, the second assay in the ARIES pipeline, represents another milestone for Luminex. Given our progress to date, and our growing momentum, we are confident in our ability to maintain the current timelines for commercial launch of the ARIES platform scheduled for the fourth quarter of this year."

Luminex expects its FDA submission for the ARIES platform and ARIES HSV 1&2 Assay to occur in the summer of 2015. The clinical trials for the ARIES C. difficile Assay are being conducted at several clinical laboratories in the U.S.

SOURCE Luminex Corporation

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Luminex. (2015, April 28). Luminex provides clinical trial update on ARIES HSV 1&2 Assay. News-Medical. Retrieved on November 30, 2021 from https://www.news-medical.net/news/20150428/Luminex-provides-clinical-trial-update-on-ARIES-HSV-12-Assay.aspx.

  • MLA

    Luminex. "Luminex provides clinical trial update on ARIES HSV 1&2 Assay". News-Medical. 30 November 2021. <https://www.news-medical.net/news/20150428/Luminex-provides-clinical-trial-update-on-ARIES-HSV-12-Assay.aspx>.

  • Chicago

    Luminex. "Luminex provides clinical trial update on ARIES HSV 1&2 Assay". News-Medical. https://www.news-medical.net/news/20150428/Luminex-provides-clinical-trial-update-on-ARIES-HSV-12-Assay.aspx. (accessed November 30, 2021).

  • Harvard

    Luminex. 2015. Luminex provides clinical trial update on ARIES HSV 1&2 Assay. News-Medical, viewed 30 November 2021, https://www.news-medical.net/news/20150428/Luminex-provides-clinical-trial-update-on-ARIES-HSV-12-Assay.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease